找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Evidence-based Therapy in Vascular Surgery; E. Sebastian Debus,Reinhart T. Grundmann Book 20171st edition The Editor(s) (if applicable) an

[復(fù)制鏈接]
樓主: 變更
11#
發(fā)表于 2025-3-23 11:50:19 | 只看該作者
12#
發(fā)表于 2025-3-23 14:08:34 | 只看該作者
13#
發(fā)表于 2025-3-23 19:01:10 | 只看該作者
14#
發(fā)表于 2025-3-23 23:11:04 | 只看該作者
https://doi.org/10.1007/978-981-13-8149-2e are no evidence-based recommendations showing that one method is more advantageous than the other. The type of revascularization must be chosen with regard to patient comorbidity, degree of ulceration, extent of the arterial lesion, and available expertise of the center. Diabetic foot osteomyeliti
15#
發(fā)表于 2025-3-24 03:43:01 | 只看該作者
Andrzej Zi?bik,Krzysztof Hoinka be considered as an alternative to CEA in high-volume centres with documented death or stroke rate <3% in asymptomatic patients, and <6% in symptomatic patients, respectively. Especially, women younger than 75 years of age, patients with contralateral occlusion and restenosis have no increased risk with CAS compared to CEA.
16#
發(fā)表于 2025-3-24 07:08:40 | 只看該作者
https://doi.org/10.1007/978-3-319-48220-0are outlined. For the uncomplicated forms a conservative approach is recommended, complicated forms require endovascular stent grafting or an open surgical procedure. Although randomized studies are missing, the results of retrospective case series and register-related studies favor the endovascular treatment over open surgery.
17#
發(fā)表于 2025-3-24 11:56:55 | 只看該作者
18#
發(fā)表于 2025-3-24 16:29:07 | 只看該作者
19#
發(fā)表于 2025-3-24 20:02:02 | 只看該作者
André Dorsman,Wim Westerman,John L. Simpson Renal artery angioplasty and stenting may be considered for patients with RAS and complicated, uncontrolled hypertension. Surgery remains the primary approach for patients with complex lesions of arterial bifurcation or branches, stenoses associated with complex aneurysms, or following PTA failure.
20#
發(fā)表于 2025-3-24 23:47:25 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 08:30
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
铜陵市| 长治市| 辽阳县| 五大连池市| 大厂| 河西区| 鹿邑县| 台东市| 台南市| 大方县| 齐河县| 太仓市| 山丹县| 石家庄市| 古浪县| 朔州市| 兰考县| 友谊县| 南阳市| 顺平县| 海城市| 郸城县| 沈丘县| 德化县| 张家界市| 成安县| 寿光市| 通江县| 阿拉尔市| 克东县| 沈阳市| 黔南| 云和县| 濮阳县| 罗江县| 久治县| 鹤庆县| 永昌县| 和田市| 论坛| 云南省|